Max Rubin MBA

Managing Partner

Max Rubin

As the managing partner of Cambridge Healthcare Research, Max is responsible for company growth and business development. He also heads CHR’s Rare Diseases division, supporting client product strategy in over a dozen rare diseases.

Max is an experienced consultant with a broad background in strategic consulting and the pharmaceutical industry. He has led projects supporting pharmaceutical and biotech companies in a wide range of commercial strategy issues, including forecasting, market assessments, competitive threat analysis and launch planning. Max’s client work has encompassed multiple therapeutic areas, amongst them neurology, endocrinology, haematology, vaccines and regenerative medicine.

Max holds an MBA from the University of Cambridge and a BSc in Biotechnology from Tel Aviv University. Prior to CHR, he was a Senior Consultant and Engagement Manager at a life science consultancy, and a Project Manager at Teva Pharmaceuticals.

In his free time, Max enjoys running along the river Cam (and through the green parts of any city business travel brings him to), camping with his wife and two boys, and listening to alternative rock.

Matteo Perucchini PhD


Edward Cartwright PhD


Laura Lawrence

Head of Operations

Nick Tait

Financial Director

Stella Wooder PhD

Strategic Advisor

Marjorie Norman MBA

Strategic Advisor

Chris Stevenson

Strategic Adviser

Aarti Ruparelia PhD


Jacky Kourieh PhD

Senior Consultant

Luke Lee PhD

Senior Associate Consultant

Zöe Stephenson PhD


Hugh Sowley PhD

Senior Associate Consultant

Diana Di Paolo PhD


Kaiser Karamdad PhD

Senior Associate Consultant

Vera Malheiro PhD

Senior Associate

Simon Vanstone PhD

Senior Associate Consultant

Emma Goffin BSc and MSc


Isabel Diez-Sevilla PhD


Jonathan Barrow PhD


More team members

Are you passionate about healthcare?

We’re always looking for bright and resourceful individuals, passionate about healthcare and who can help us provide an outstanding service to our clients.